T1	PROC 44 58	Ensayo abierto
T2	PROC 64 110	evaluar la eficacia, seguridad y tolerabilidad
T3	CHEM 114 121	HZN-825
T4	LIVB 125 134	pacientes
#1	AnnotatorNotes T4	C0030705; Patients; Patient or Disabled Group
T5	DISO 139 174	esclerosis sistémica cutánea difusa
T6	PROC 195 236	Ensayo de extensión abierto multicéntrico
T7	PROC 242 288	evaluar la eficacia, seguridad y tolerabilidad
T8	CHEM 292 299	HZN-825
T9	LIVB 303 312	pacientes
#2	AnnotatorNotes T9	C0030705; Patients; Patient or Disabled Group
T10	DISO 317 352	esclerosis sistémica cutánea difusa
T11	DISO 374 384	Enfermedad
#3	AnnotatorNotes T11	C0012634; Disease; Disease or Syndrome | C0221423; Illness (finding); Sign or Symptom
T12	DISO 406 430	engrosamiento de la piel
#4	AnnotatorNotes T12	C0334008; Pachyderma; Pathologic Function
T13	DISO 432 440	fibrosis
#5	AnnotatorNotes T13	C0016059; Fibrosis; Pathologic Function
T14	DISO 444 456	problemas en
T15	DISO 464 482	órganos del cuerpo
T16	DISO 507 542	Esclerosis sistémica cutánea difusa
T17	PROC 572 608	Consentimiento informado por escrito
T18	PROC 637 660	tratamiento doble ciego
T19	Date 662 671	semana 52
T20	LIVB 708 715	sujetos
#6	AnnotatorNotes T20	C0681850; Study Subject; Group
T21	PROC 720 762	suspendieron prematuramente el tratamiento
T22	CHEM 770 777	fármaco
#7	AnnotatorNotes T22	C0013227; Pharmaceutical Preparations; Pharmacologic Substance
T23	DISO 859 868	toxicidad
#8	AnnotatorNotes T23	C0600688; Toxic effect; Injury or Poisoning
T24	LIVB 904 916	investigador
#9	AnnotatorNotes T24	C0035173; Research Personnel; Professional or Occupational Group
T25	PROC 946 953	visitas
T26	PROC 1009 1021	evaluaciones
#10	AnnotatorNotes T26	C1261322; Evaluation procedure; Health Care Activity
T27	Date 1025 1037	la semana 52
T28	LIVB 1043 1049	Sujeto
#11	AnnotatorNotes T28	C0681850; Study Subject; Group
T29	PROC 1085 1094	protocolo
#12	AnnotatorNotes T29	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T30	PROC 1098 1109	tratamiento
#13	AnnotatorNotes T30	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T31	PROC 1110 1119	prescrito
#14	AnnotatorNotes T31	C0033080; Prescription procedure; Health Care Activity
T32	PROC 1126 1138	evaluaciones
#15	AnnotatorNotes T32	C1261322; Evaluation procedure; Health Care Activity
T33	CHEM 1214 1238	fármaco en investigación
T34	PROC 1244 1250	tratar
T35	DISO 1261 1271	enfermedad
#16	AnnotatorNotes T35	C0012634; Disease; Disease or Syndrome | C0221423; Illness (finding); Sign or Symptom
T36	PROC 1316 1327	diagnóstico
#17	AnnotatorNotes T36	C0011900; Diagnosis; Diagnostic Procedure
T37	DISO 1331 1348	neoplasia maligna
#18	AnnotatorNotes T37	C0006826; Malignant Neoplasms; Neoplastic Process | C1306459; Primary malignant neoplasm; Neoplastic Process
T38	Neg_cue 1403 1410	excepto
T39	DISO 1411 1460	carcinoma de células basales/escamosas de la piel
T40	Negated 1411 1460	carcinoma de células basales/escamosas de la piel
T41	DISO 1463 1488	cáncer de cuello de útero
T42	Negated 1463 1488	cáncer de cuello de útero
T43	PROC 1500 1507	tratado
T44	LIVB 1538 1560	Mujeres en edad fértil
T45	Age 1549 1560	edad fértil
T46	LIVB 1562 1565	MEF
T47	LIVB 1569 1576	varones
T48	Neg_cue 1581 1583	no
T49	PROC 1609 1632	métodos anticonceptivos
#19	AnnotatorNotes T49	C0700589; Contraceptive methods; Therapeutic or Preventive Procedure
T50	Negated 1609 1632	métodos anticonceptivos
T51	Negated 1633 1652	altamente efectivos
T52	Duration 1686 1695	4 semanas
T53	CHEM 1727 1734	fármaco
#20	AnnotatorNotes T53	C0013227; Pharmaceutical Preparations; Pharmacologic Substance
T54	LIVB 1751 1758	varones
T55	Neg_cue 1765 1778	abstenerse de
T56	PROC 1779 1792	donar esperma
T57	Negated 1779 1792	donar esperma
T58	LIVB 1800 1807	mujeres
#21	AnnotatorNotes T58	C0043210; Woman; Population Group | C0242665; wife; Family Group
T59	PROC 1811 1823	donar óvulos
T60	Negated 1811 1823	donar óvulos
T61	LIVB 1884 1889	mujer
#22	AnnotatorNotes T61	C0043210; Woman; Population Group | C0242665; wife; Family Group
T62	Age 1898 1909	edad fértil
T63	PHYS 1932 1945	posmenopausia
#23	AnnotatorNotes T63	C0206159; Postmenopause; Organism Function
T64	Neg_cue 1948 1950	no
T65	PROC 1972 1997	esterilización quirúrgica
T66	Negated 1972 1997	esterilización quirúrgica
T67	PROC 2007 2031	salpingectomía bilateral
T68	PROC 2033 2055	ooforectomía bilateral
#24	AnnotatorNotes T68	C0278321; Bilateral oophorectomy; Therapeutic or Preventive Procedure
T69	PROC 2058 2071	histerectomía
#25	AnnotatorNotes T69	C0020699; Hysterectomy; Therapeutic or Preventive Procedure
T70	PHYS 2090 2111	estado posmenopáusico
#26	AnnotatorNotes T70	C0206159; Postmenopause; Organism Function
T71	Date 2097 2111	posmenopáusico
T72	Neg_cue 2130 2141	ausencia de
T73	PHYS 2142 2154	menstruación
#27	AnnotatorNotes T73	C0025344; Menstruation; Organism Function
T74	Negated 2142 2154	menstruación
T75	Duration 2163 2171	12 meses
T76	Neg_cue 2172 2175	sin
T77	Negated 2180 2192	causa médica
T78	CHEM 2230 2257	hormona foliculoestimulante
#28	AnnotatorNotes T78	C0733758; follicle stimulating hormone; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T79	CHEM 2259 2262	FSH
#29	AnnotatorNotes T79	C0733758; follicle stimulating hormone; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance
T80	Date 2281 2295	posmenopáusico
T81	Speculated 2315 2324	confirmar
T82	PHYS 2328 2349	estado posmenopáusico
#30	AnnotatorNotes T82	C0206159; Postmenopause; Organism Function
T83	Date 2335 2349	posmenopáusico
T84	LIVB 2353 2360	mujeres
#31	AnnotatorNotes T84	C0043210; Woman; Population Group | C0242665; wife; Family Group
T85	Neg_cue 2365 2367	no
T86	CHEM 2373 2399	anticonceptivos hormonales
T87	Negated 2373 2399	anticonceptivos hormonales
T88	PROC 2402 2432	terapia de reposición hormonal
T89	Negated 2402 2432	terapia de reposición hormonal
T90	Neg_cue 2450 2461	ausencia de
T91	Duration 2462 2470	12 meses
T92	Negated 2462 2470	12 meses
T93	PHYS 2474 2483	amenorrea
T94	Negated 2474 2483	amenorrea
T95	PROC 2494 2512	medición de la FSH
#32	AnnotatorNotes T95	C0202022; Follicle stimulating hormone measurement; Laboratory Procedure
T96	LIVB 2534 2550	varones fértiles
T97	PROC 2557 2578	utilizar preservativo
T98	Duration 2612 2621	4 semanas
T99	CHEM 2653 2660	fármaco
#33	AnnotatorNotes T99	C0013227; Pharmaceutical Preparations; Pharmacologic Substance
T100	LIVB 2676 2681	varón
T101	PHYS 2716 2724	pubertad
#34	AnnotatorNotes T101	C0034011; Puberty; Physiologic Function
T102	DISO 2757 2764	estéril
#35	AnnotatorNotes T102	C0021359; Infertility; Pathologic Function
T103	PROC 2769 2791	orquiectomía bilateral
#36	AnnotatorNotes T103	C0007347; Male Castration; Therapeutic or Preventive Procedure
T104	LIVB 2797 2842	Mujeres embarazadas o en período de lactancia
T105	DISO 2874 2884	enfermedad
#37	AnnotatorNotes T105	C0012634; Disease; Disease or Syndrome | C0221423; Illness (finding); Sign or Symptom
T106	LIVB 2902 2908	sujeto
#38	AnnotatorNotes T106	C0681850; Study Subject; Group
T107	LIVB 3015 3027	investigador
#39	AnnotatorNotes T107	C0035173; Research Personnel; Professional or Occupational Group
T108	Spec_cue 3029 3035	podría
T109	LIVB 3045 3051	sujeto
#40	AnnotatorNotes T109	C0681850; Study Subject; Group
T110	Speculated 3058 3064	riesgo
T111	Speculated 3065 3076	inaceptable
T112	LIVB 3085 3092	sujetos
#41	AnnotatorNotes T112	C0681850; Study Subject; Group
T113	Neg_cue 3093 3095	no
T114	Negated 3102 3111	elegibles
T115	LIVB 3131 3143	investigador
#42	AnnotatorNotes T115	C0035173; Research Personnel; Professional or Occupational Group
T116	Spec_cue 3148 3161	poco probable
T117	Speculated 3166 3190	cumplan con el protocolo
T118	PROC 3181 3190	protocolo
#43	AnnotatorNotes T118	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T119	DISO 3215 3225	enfermedad
#44	AnnotatorNotes T119	C0012634; Disease; Disease or Syndrome | C0221423; Illness (finding); Sign or Symptom
T120	DISO 3228 3249	afección concomitante
T121	Spec_cue 3254 3259	pueda
T122	Speculated 3260 3270	interferir
